April 8, 1997
Integrated Health Services Inc. dropped its $551.5-million bid to acquire Coram Healthcare Corp., scuttling plans to create one of the largest U.S. home-health-care companies. The decision was made in part because of a disagreement over litigation tied to Coram's 1995 acquisition of a Caremark International Inc. unit, Coram said. . . . The Federal Trade Commission has opened an inquiry into whether ads by Miller Brewing Co., a unit of Philip Morris Cos.
October 22, 1996 |
Integrated Health Services Inc. announced Monday that it plans to buy Coram Healthcare for $655 million, creating the nation's second-largest home health company. The combined company, which would keep the Integrated Health name, would operate more than 700 home health branch locations in 44 states, including California. Coram shareholders would get stock valued at about $280 million, and Integrated Health would also assume Coram's debt and other financial obligations, valued at $375 million.
April 19, 1995 |
Coram Healthcare Corp. has agreed to acquire Lincare Holdings Inc. in a $1-billion stock deal that would give Coram a big presence in the home respiratory market, the companies said Tuesday. Denver-based Coram said it is the nation's largest provider of home infusion therapy and that Lincare is the second-largest provider of home respiratory therapy. Under the deal, Lincare stockholders would receive 1.54 shares of Coram common stock for each share of Lincare.
February 1, 1995 |
Abbey Healthcare Group's stock gained 3.6% Tuesday amid reports that the Costa Mesa home health-care provider is in talks to be acquired by Coram Healthcare Corp. Abbey's stock rose 87.5 cents a share to close at $25.50 in Nasdaq trading. Neither Abbey nor Coram, based in Denver, would comment on the rumor, and analysts who cover the two companies said they were unaware of any discussions. But some said there are reasons to think that an acquisition might be in the works.
September 27, 1994 |
In what could be an important precedent for the federal government in its efforts to enforce anti-kickback laws in the medical industry, a unit of a Newport Beach home infusion company said Monday that it has agreed to pay $500,000 to end a federal probe of its financial relations with doctors. To settle fraud charges brought by the U.S. Department of Health and Human Services, T2 Medical Inc., an Atlanta-based unit of Coram Healthcare Corp.